Regarding the significant prevalence of loss-of-function CFTR alleles/variants in the most severe clinical categories, the finding is in accordance with our previous work [17] and the work of others [45] showing that carriers of single pathogenic CFTR variants are more likely to undergo severe COVID-19 with a high risk of 14-day mortality [17]). The gene discussed is CFTR; the disease is COVID-19.